Champions Oncology (STU:2I3) Total Stockholders Equity : €0.63 Mil (As of Oct. 2024)

View and export this data going back to 2018. Start your Free Trial

What is Champions Oncology Total Stockholders Equity?

Champions Oncology's Total Stockholders Equity for the quarter that ended in Oct. 2024 was €0.63 Mil. It refers to the net assets owned by shareholders. It does not include minority interest.

Total Stockholders Equity is used to calculate Book Value per Share. Champions Oncology's Book Value per Share for the quarter that ended in Oct. 2024 was €0.05. The ratio of a company's debt over equity can be used to measure how leveraged this company is. Champions Oncology's Debt-to-Equity for the quarter that ended in Oct. 2024 was 9.95.

Champions Oncology Total Stockholders Equity Historical Data

The historical data trend for Champions Oncology's Total Stockholders Equity can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Champions Oncology Total Stockholders Equity Chart

Champions Oncology Annual Data

Trend

Apr15

Apr16

Apr17

Apr18

Apr19

Apr20

Apr21

Apr22

Apr23

Apr24

Total Stockholders Equity

Get a 7-Day Free Trial

4.69

6.21

8.42

4.23

-1.77

Champions Oncology Quarterly Data
	Jan20	Apr20	Jul20	Oct20	Jan21	Apr21	Jul21	Oct21	Jan22	Apr22	Jul22	Oct22	Jan23	Apr23	Jul23	Oct23	Jan24	Apr24	Jul24	Oct24
Total Stockholders Equity	Get a 7-Day Free Trial															0.09	-1.89	-1.77	-0.31	0.63

Champions Oncology (STU:2I3) Total Stockholders Equity Explanation

1. Total Stockholders Equity is used to calculate Book Value per Share.

Champions Oncology's Book Value per Share for the quarter that ended in Oct. 2024 is

Book Value per Share	=	(Total Stockholders Equity	-	Preferred Stock)	/	Shares Outstanding (EOP)
	=	(0.625	-	0)	/	13.6989
	=	0.05

2. The ratio of a company's debt over equity can be used to measure how leveraged this company is.

Champions Oncology's Debt-to-Equity for the quarter that ended in Oct. 2024 is

Debt-to-Equity	=	Total Debt			/	Total Stockholders Equity
	=	(Short-Term Debt & Capital Lease Obligation	+	Long-Term Debt & Capital Lease Obligation)	/	Total Stockholders Equity
	=	(1.286	+	4.933)	/	0.625
	=	9.95

Champions Oncology Total Stockholders Equity Related Terms

Thank you for viewing the detailed overview of Champions Oncology's Total Stockholders Equity provided by GuruFocus.com. Please click on the following links to see related term pages.

Champions Oncology Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Champions Oncology Inc (STU:2I3) » Definitions » Total Stockholders Equity

Comparable Companies

Traded in Other Exchanges

CSBR:USA

Address

One University Plaza, Suite 307, Hackensack, NJ, USA, 07601

Website

https://www.championsoncology.com

Champions Oncology Inc is a USA based company which is engaged in the development and sale of state of the art technology solutions and products to personalize the development and use of oncology drugs. The company operates through one segment namely Personalized Oncology Solutions (POS) and Translational Oncology Solutions (TOS). Its POS business assists physicians in developing personalized treatment options for their cancer patients through tumor-specific data obtained from drug panels and related personalized oncology services. The TOS business assists pharmaceutical and biotechnology companies with their drug development process and offers studies or license tumors for use in studies. The company's revenue is majorly derived from research services.

Champions Oncology Headlines

No Headlines